1.The Prevalence and Clinical Characteristics of Hepatitis-delta Infection in Korea.
Sook Hyang JEONG ; Jung Min KIM ; Heui June AHN ; Myung Joon PARK ; Kwang Hyun PAIK ; Won CHOI ; Jin KIM ; Chul Joo HAN ; Yoo Cheoul KIM ; Jhin Oh LEE ; Young Joon HONG ; Hyo Young PARK ; Ha Hyun JEONG ; Mi Yong YOON ; Myungjin LEE ; Kee Ho LEE
The Korean Journal of Hepatology 2005;11(1):43-50
BACKGROUND/AIMS: The prevalence of hepatitis delta virus (HDV) infection has been estimated as being approximately 5% among global HBsAg carriers. The anti-delta positive rate in Koreans had been reported as being 0.85% in 1985. While the prevalence of HBV has been decreased from nearly 10% to 5% during the past twenty years, there have been no more studies on the anti-delta prevalence in Koreans. The aim of this study was to estimate the anti-delta prevalence in Koreans and to study the clinical characteristics of anti-delta positive patients in a single center. METHODS: Serum anti-delta was measured in one hundred ninety four HBsAg-positive patients who were admitted to our hospital from February 2003 to August 2003. We checked the genotypes of the HBV in the anti-delta positive patients. The clinical features of the anti-delta positive patients were compared to those clinical features of the anti-delta negative patients from the aspect of age, gender, mode of transmission, the positivity of HBeAg and serum HBV DNA. RESULTS: Serum anti-delta was positive in seven patients among the 194 subjects, giving a 3.6% positive rate. Among these seven patients, six had hepatocellular carcinoma (HCC) and the other one had cholangiocarcinoma. All of the anti-delta positive patients had the C genotype of HBV. The anti-delta positive patients showed significantly suppressed HBV DNA replication compared to the anti-delta negative patients. CONCLUSIONS: In Koreans, anti-delta was positive mainly in HCC patients with an approximate prevalence of 4%, and this rate has not changed much for the past twenty years. HBV DNA replication was suppressed by HDV infection.
Adult
;
Carcinoma, Hepatocellular/virology
;
English Abstract
;
Female
;
Hepatitis Antibodies/analysis
;
Hepatitis D/complications/*epidemiology/immunology
;
Hepatitis Delta Virus/immunology
;
Hepatitis delta Antigens/analysis
;
Humans
;
Korea/epidemiology
;
Liver Neoplasms/virology
;
Male
;
Middle Aged
;
Prevalence
2.Inactive hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study.
Nese DEMIRTURK ; Tuna DEMIRDAL
Clinical and Molecular Hepatology 2014;20(1):56-60
BACKGROUND/AIMS: The aims of the present study were to determine the outcomes of inactive hepatitis B virus (HBV) surface antigen (HBsAg) carriers over a 10-year study period and to elucidate the HBV serological profile of their family members. METHODS: We retrospectively analyzed the medical files of inactive HBsAg carriers followed up at the Department of Infectious Diseases of Kocatepe University Medical Faculty Hospital between March 2001 and January 2011. RESULTS: In total, 438 inactive HBsAg carriers were enrolled in this trial. The follow-up period was 33.7+/-22.5 months (mean+/-SD). Anti-hepatitis-B surface antibody seroconversion occurred in 0.7% of cases, while chronic hepatitis B was found in 0.5%. The anti-hepatitis-D virus (HDV) status was evaluated in 400 patients and anti-hepatitis C virus (HCV) in 430. It was found that 1% and 0.2% were positive for anti-HDV and anti-HCV, respectively. HBV serology was investigated in at least 1 family member of 334/438 (76.3%) patients. The HBsAg positivity rate was 34.6% in 625 family members of 334 patients. A comparison of the HBsAg positivity rates in terms of HBV DNA levels in index cases revealed that HBsAg seropositivity rates were higher in family members of HBV DNA-negative patients than in family members of HBV DNA-positive cases (P=0.0001). CONCLUSIONS: The HBsAg positivity rate was higher in family members of inactive HBsAg carriers than in the general population; these family members therefore have a higher risk of HBV transmission. Furthermore, despite negative HBV DNA levels, transmission risk was not reduced in these patients, and horizontal transmission seems to be independent of the HBV DNA value.
Adult
;
Antibodies/blood
;
Carrier State
;
DNA, Viral/analysis
;
Family Health
;
Female
;
Follow-Up Studies
;
Hepatitis B Antibodies/blood
;
Hepatitis B Surface Antigens/*blood
;
Hepatitis B virus/genetics/immunology
;
Hepatitis B, Chronic/*diagnosis/transmission/virology
;
Hepatitis Delta Virus/immunology
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies